IQVIA Announces Opening of New Q² Solutions Innovation Laboratories in North Carolina, Creating New Jobs and Expanded Capabilities
October 06, 2021 at 08:00 am EDT
Share
IQVIA announced the opening of a state-of-the-art, 160,000-square-foot lab facility for its Second Quarter Solutions subsidiary. These custom-designed laboratory spaces will be known as Q2Solutions Innovation Laboratories and are located on the new IQVIA Innovation Park Campus in the heart of the dynamic Research Triangle Park in North Carolina. Through a collaboration with the North Carolina Department of Commerce and the Economic Development Partnership of North Carolina, IQVIA anticipates that this new facility will create up to 750 new jobs in North Carolina over the next 10 years. The new facility has an innovative suite of laboratory capabilities, including cutting edge bioanalytical, vaccine, biomarker and genomics laboratories. The site is also home to a new Translational Science and Innovation Laboratory (TSAIL). TSAIL will allow customers to access a broad range of services including a cross-disciplined approach to early-stage Research & Development and exploratory human biomarker activities. This will enable biopharmaceutical companies to accelerate drug development.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows:
- development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes;
- development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers;
- integrated services (5.6%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc.
Net sales are distributed geographically as follows: Americas (49.4%), Europe and Africa (31.4%) and Asia/Pacific (19.2%).